Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.

Sun, Bo; Hyun, Hyesun; Li, Lian-Tao; Wang, Andrew Z

Sun, Bo; Hyun, Hyesun; Li, Lian-Tao; Wang, Andrew Z.

Afiliação

Sun B; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, 85721, USA.
Hyun H; Laboratory of Nano and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Li LT; Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Wang AZ; Cancer Institute, Xuzhou Medical University, Xuzhou, 221004, China.

Acta Pharmacol Sin ; 41(7): 970-985, 2020 Jul.

Article em En | MEDLINE | ID: mdl-32424240

Assuntos

Fatores Imunológicos/farmacologia; Imunoterapia; Nanomedicina; Neoplasias/terapia; Humanos; Neoplasias/imunologia; Microambiente Tumoral/efeitos dos fármacos

Palavras-chave

cancer immunotherapy; cytokines; enzymes; immune cells; immunosuppression; nanomedicine; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanomedicina / Fatores Imunológicos / Imunoterapia / Neoplasias Limite: Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google